Plasental Anomaliler ve Plasenta Akreta Spektrumu Yönetimi

Irving C, Hertig AT. A study of placenta accreta. Surgery, Gynecology & Obstetrics. 1937; 64, 178–200.

Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. American Journal of Obstetrics and Gynecology. 1966;95(5):660-668. doi:10.1016/s0002-9378(16)34741-x

Jauniaux E, Silver RM, Matsubara S. The new world of placenta accreta spectrum disorders. International Journal of Gynaecology and Obstetrics. 2018;140(3):259-260. doi:10.1002/ijgo.12433

Jauniaux E, Kingdom JC, Silver RM. A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2021;72:102-116. doi:10.1016/j.bpobgyn.2020.06.007

Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. International Journal of Gynaecology and Obstetrics. 2019;146(1):20-24. doi:10.1002/ijgo.12761

Salmanian B, Shainker SA, Hecht JL, et al. The Society for Pediatric Pathology Task Force grading system for placenta accreta spectrum and its correlation with clinical outcomes. American Journal of Obstetrics and Gynecology. 2022;226(5):720.e1-720.e6. doi:10.1016/j.ajog.2022.02.002

Matsuo K, Einerson BD, Matsuzaki S, et al. Nationwide Assessment of Gestational Age Distribution at Delivery for Patients With Placenta Accreta Spectrum Disorder. Obstetrics and Gynecology. 2025;145(6):654-663. doi:10.1097/AOG.0000000000005849

Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstetrics and Gynecology. 1980;56(1):31-34.

White A, Malik M, Pruszynski JE, et al. Contemporary Placenta Accreta Spectrum Disorder Incidence and Risk Factors. Obstetrics and Gynecology. 2025;145(6):665-673. doi:10.1097/AOG.0000000000005919

Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2019;221(3):208-218. doi:10.1016/j.ajog.2019.01.233

Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstetrics and Gynecology. 2006;107(6):1226-1232. doi:10.1097/01.AOG.0000219750.79480.84

Timor-Tritsch IE, Monteagudo A, Cali G, et al. Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound in Obstetrics & Gynecology. 2014;44(3):346-353. doi:10.1002/uog.13426

Kaser DJ, Melamed A, Bormann CL, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertility and Sterility. 2015;103(5):1176-84.e2. doi:10.1016/j.fertnstert.2015.01.021

Baldwin HJ, Patterson JA, Nippita TA, et al. Antecedents of Abnormally Invasive Placenta in Primiparous Women: Risk Associated With Gynecologic Procedures. Obstetrics and Gynecology. 2018;131(2):227-233. doi:10.1097/AOG.0000000000002434

Afshar Y, Yin O, Jeong A, et al. Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium. American Journal of Obstetrics and Gynecology. 2024;230(4):443.e1-443.e18. doi:10.1016/j.ajog.2023.10.001

Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. American Journal of Obstetrics and Gynecology. 2015;212(5):561-568. doi:10.1016/j.ajog.2014.11.018

Jauniaux E, Chantraine F, Silver RM, et al; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. International Journal of Gynaecology and Obstetrics. 2018;140(3):265-273. doi:10.1002/ijgo.12407

Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. American Journal of Obstetrics and Gynecology. 2015;212(2):218.e1-218.e2189. doi:10.1016/j.ajog.2014.08.019

Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstetrics and Gynecology. 2011;117(2 Pt 1):331-337. doi:10.1097/AOG.0b013e3182051db2

Grace Tan SE, Jobling TW, Wallace EM, et al. Surgical management of placenta accreta: a 10-year experience. Acta Obstetricia et Gynecologica Scandinavica. 2013;92(4):445-450. doi:10.1111/aogs.12075

Givens M, Valcheva I, Einerson BD, et al. Evaluation of maternal serum protein biomarkers in the prenatal evaluation of placenta accreta spectrum: A systematic scoping review. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(12):2335-2347. doi:10.1111/aogs.14918

Pagani G, Cali G, Acharya G, et al. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica. 2018;97(1):25-37. doi:10.1111/aogs.13238

Sugai S, Yamawaki K, Sekizuka T, et al. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM. 2023;5(12):101197. doi:10.1016/j.ajogmf.2023.101197

Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG: an international journal of obstetrics and gynaecology. 2014;121(1):62-71. doi:10.1111/1471-0528.12405

Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG: an international journal of obstetrics and gynaecology. 2016;123(8):1348-1355. doi:10.1111/1471-0528.13547

Melcer Y, Jauniaux E, Maymon S, et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. American Journal of Obstetrics and Gynecology. 2018;218(4):443.e1-443.e8. doi:10.1016/j.ajog.2018.01.017

Jauniaux E, Hussein AM, Thabet MM, et al. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth. American Journal of Obstetrics and Gynecology. 2023;229(4):445.e1-445.e11. doi:10.1016/j.ajog.2023.05.004

Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for the prediction of placenta accreta. American Journal of Obstetrics and Gynecology. 2014;211(2):177.e1-177.e1777. doi:10.1016/j.ajog.2014.03.029

Maldjian C, Adam R, Pelosi M, et al. MRI appearance of placenta percreta and placenta accreta. Magnetic Resonance Imaging. 1999;17(7):965-971. doi:10.1016/s0730-725x(99)00035-1

Waller J, Shamshirsaz A, Abuhamad A. Advances in Imaging for Placenta Accreta Spectrum Disorder. Obstetrics and Gynecology. 2025;145(6):621-627. doi:10.1097/AOG.0000000000005905

De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, et al. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology. 2022;59(4):428-436. doi:10.1002/uog.24861

Einerson BD, Rodriguez CE, Kennedy AM, et al. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. American Journal of Obstetrics and Gynecology. 2018;218(6):618.e1-618.e7. doi:10.1016/j.ajog.2018.03.013

Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, et al. MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. AJR American Journal of Roentgenology. 2017;208(1):214-221. doi:10.2214/AJR.16.16281

Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016;316(9):952-961. doi:10.1001/jama.2016.12126

McDonald RJ, Levine D, Weinreb J, et al. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology. 2018;289(2):517-534. doi:10.1148/radiol.2018181151

Jha P, Pōder L, Bourgioti C, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. European Radiology. 2020;30(5):2604-2615. doi:10.1007/s00330-019-06617-7

Bourgioti C, Zafeiropoulou K, Fotopoulos S, et al. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders. Journal of Magnetic Resonance Imaging. 2019;50(2):602-618. doi:10.1002/jmri.26592

Calí G, Timor-Tritsch IE, Forlani F, et al. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound in Obstetrics and Gynecology. 2020;55(4):450-459. doi:10.1002/uog.21939

Doulaveris G, Ryken K, Papathomas D, et al. Early prediction of placenta accreta spectrum in women with prior cesarean delivery using transvaginal ultrasound at 11 to 14 weeks. American Journal of Obstetrics & Gynecology MFM. 2020;2(4):100183. doi:10.1016/j.ajogmf.2020.100183

Abinader RR, Macdisi N, El Moudden I, et al. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy. Ultrasound in Obstetrics and Gynecology. 2022;59(4):457-464. doi:10.1002/uog.24828

Han X, Guo Z, Yang X, et al. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder. JAMA Network Open. 2022;5(8):e2228002. Published 2022 Aug 1. doi:10.1001/jamanetworkopen.2022.28002

Collins SL, Alemdar B, van Beekhuizen HJ, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. American Journal of Obstetrics and Gynecology. 2019;220(6):511-526. doi:10.1016/j.ajog.2019.02.054

Merrill J, Sultan P, Sharawi N. Advances in anesthetic and obstetric management of patients with placenta accreta spectrum. Current Opinion in Anaesthesiology. 2021;34(3):260-268. doi:10.1097/ACO.0000000000000985

Bartels HC, Rogers AC, O'Brien D, et al. Association of Implementing a Multidisciplinary Team Approach in the Management of Morbidly Adherent Placenta With Maternal Morbidity and Mortality. Obstetrics and Gynecology. 2018;132(5):1167-1176. doi:10.1097/AOG.0000000000002865

Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstetricia et Gynecologica Scandinavica. 2011;90(10):1140-1146. doi:10.1111/j.1600-0412.2011.01147.x

Schwickert A, van Beekhuizen HJ, Bertholdt C, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study. Acta Obstetricia et Gynecologica Scandinavica. 2021;100 Suppl 1:29-40. doi:10.1111/aogs.14103

Pri-Paz S, Fuchs KM, Gaddipati S, et al. Comparison between emergent and elective delivery in women with placenta accreta. The Journal of Maternal-Fetal&Neonatal Medicine. 2013;26(10):1007-1011. doi:10.3109/14767058.2013.766711

Munoz JL, Ramsey PS, Greebon LJ, et al. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2024;293:32-35. doi:10.1016/j.ejogrb.2023.12.006

Lucidi A, Jauniaux E, Hussein AM, et al. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology. 2023;62(5):633-643. doi:10.1002/uog.26299

Scaglione MA, Allshouse AA, Canfield DR, et al. Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and Gynecology. 2022;140(5):806-811. doi:10.1097/AOG.0000000000004957

Horgan R, Hessami K, Hage Diab Y, et al. Prophylactic ureteral stent placement for the prevention of genitourinary tract injury during hysterectomy for placenta accreta spectrum: systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM. 2023;5(10):101120. doi:10.1016/j.ajogmf.2023.101120

Bishop S, Butler K, Monaghan S, et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. International Journal of Obstetrics Anesthesia. 2011;20(1):70-73. doi:10.1016/j.ijoa.2010.09.012

Lilker SJ, Meyer RA, Downey KN, et al. Anesthetic considerations for placenta accreta. International Journal of Obstetric Anesthesia. 2011;20(4):288-292. doi:10.1016/j.ijoa.2011.06.001

Ordoñez CA, Manzano-Nunez R, Parra MW, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: A systematic review, meta-analysis, and case series. The Journal of Trauma and Acute Care Surgery. 2018;84(5):809-818. doi:10.1097/TA.0000000000001821

Whittington JR, Pagan ME, Sharawi N, et al. REBOA placement for placenta accreta spectrum: patient selection and utilization. The Journal of Maternal-Fetal & Neonatal Medicine. 2022;35(25):6440-6441. doi:10.1080/14767058.2021.1914580

Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period. American Journal of Obstetrics and Gynecology. 2018;218(1):B2-B8. doi:10.1016/j.ajog.2017.10.019

American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstetrics and Gynecology. 2018;132(6):e259-e275. doi:10.1097/AOG.0000000000002983

Bowman ZS, Manuck TA, Eller AG, et al. Risk factors for unscheduled delivery in patients with placenta accreta. American Journal of Obstetrics and Gynecology. 2014;210(3):241.e1-241.e2416. doi:10.1016/j.ajog.2013.09.044

Clark SL, Phelan JP, Yeh SY, et al. Hypogastric artery ligation for obstetric hemorrhage. Obstetrics and Gynecology. 1985;66(3):353-356.

Papp Z, Tóth-Pál E, Papp C, et al. Hypogastric artery ligation for intractable pelvic hemorrhage. International Journal of Gynaecology and Obstetrics. 2006;92(1):27-31. doi:10.1016/j.ijgo.2005.08.022

Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstetrics and Gynecology. 2010;115(3):526-534. doi:10.1097/AOG.0b013e3181d066d4

Palacios Jaraquemada JM, Pesaresi M, Nassif JC, et al. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstetricia et Gynecologica Scandinavica. 2004;83(8):738-744. doi:10.1111/j.0001-6349.2004.00517.x

Fox KA, Shamshirsaz AA, Carusi D, et al. Conservative management of morbidly adherent placenta: expert review. American Journal of Obstetrics and Gynecology. 2015;213(6):755-760. doi:10.1016/j.ajog.2015.04.034

Legendre G, Zoulovits FJ, Kinn J, et al. Conservative management of placenta accreta: hysteroscopic resection of retained tissues. Journal of Minimally Invasive Gynecology. 2014;21(5):910-913. doi:10.1016/j.jmig.2014.04.004

Hequet D, Morel O, Soyer P, et al. Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accreta. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 2013;53(6):580-583. doi:10.1111/ajo.12138

Sentilhes L, Seco A, Azria E, et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. American Journal of Obstetrics and Gynecology. 2022;226(6):839.e1-839.e24. doi:10.1016/j.ajog.2021.12.013

Zuckerwise LC, Craig AM, Newton JM, et al. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. American Journal of Obstetrics and Gynecology. 2020;222(2):179.e1-179.e9. doi:10.1016/j.ajog.2019.08.035

Rupley DM, Tergas AI, Palmerola KL, et al. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecologic Oncology Reports. 2016;17:53-55. Published 2016 Jun 4. doi:10.1016/j.gore.2016.05.009

Steins Bisschop CN, Schaap TP, Vogelvang TE, et al. Invasive placentation and uterus preserving treatment modalities: a systematic review. Archives of Gynecology and Obstetrics. 2011;284(2):491-502. doi:10.1007/s00404-011-1934-6

Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Human Reproduction. 2010;25(11):2803-2810. doi:10.1093/humrep/deq239

Javinani A, Qaderi S, Hessami K, et al. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2024;230(5):485-492.e7. doi:10.1016/j.ajog.2023.10.047

Matsuzaki S, Einerson BD, Sentilhes L, et al. Local Resection After Cesarean Delivery for Placenta Accreta Spectrum Disorder: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. 2025;145(6):639-653. doi:10.1097/AOG.0000000000005921

Teixidor Viñas M, Belli AM, Arulkumaran S, et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. Ultrasound in Obstetrics & Gynecology. 2015;46(3):350-355. doi:10.1002/uog.14728

Piñas-Carrillo A, Chandraharan E. Conservative surgical approach: The Triple P procedure. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2021;72:67-74. doi:10.1016/j.bpobgyn.2020.07.009

Provansal M, Courbiere B, Agostini A,et al. Fertility and obstetric outcome after conservative management of placenta accreta. International Journal of Gynaecology and Obstetrics. 2010;109(2):147-150. doi:10.1016/j.ijgo.2009.12.011